Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 284-289 , July 2007

The Resurgence of Home Dialysis Therapies

  • John Moran

      Affiliations

    • Corresponding Author InformationAddress correspondence to John Moran, MB, BS, FRACP, FASN, Corporate Medical Director, WellBound, Inc., 401 Castro St., Mountain View, CA 94041.

References 

  1. U.S. Renal Data System: USRDS 2006 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  2. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice: Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–1151
  3. Liem YS, Wong JB, Hunink MGM, et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007;71:153–158
  4. Vonesh EF, Snyder JJ, Foley RN, et al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66:2389–2401
  5. U.S. Renal Data System: USRDS 1997 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1997;
  6. Robar A, Moran J. The effect of education on patient therapy choice: The WellBound experience. Denver, CO: Annual Dialysis Conference; 2007;(abstract), February
  7. Moran J, Doss S, Robar A. Results in a large short daily hemodialysis program. Am J Kidney Dis. 2006;47:A45
  8. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–2019
  9. Suri RS, Nesrallah GE, Rahul Mainra R, et al. Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol. 2006;1:33–42
  10. Spanner ED, Lindsay RM. Nutrition. Contrib Nephrol. 2004;45:89–98
  11. Lindsay RM, Alhejaili F, Nesrallah G, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis. 2003;42:24–29
  12. Rao M, Muirhead N, Klarenbach S, et al. Management of anemia with quotidian hemodialysis. Am J Kidney Dis. 2003;42:18–23
  13. Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003;42:1020–1035
  14. Ayus JC, Mizani MR, Achinger SG, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol. 2005;16:2778–2788
  15. Centers for Medicare and Medicaid Services: 2005 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, Maryland: Department of Health and Human Services, Centers for Medicare and Medicaid Services, Office of Clinical Standards and Quality; 2005;December
  16. Heidenheim AP, Kooistra MP, Lindsay RM. Quality of life. Contrib Nephrol. 2004;45:99–105
  17. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant. 2002;17:112–117

PII: S1548-5595(07)00049-3

doi: 10.1053/j.ackd.2007.03.005

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 284-289 , July 2007

Article Tools